Keeping the Life in Life Sciences

The Boston Globe
April 13, 2010

Biotech startup companies were once viewed as long-shot risk takers as they sought high-stake investments for their pioneering quest to find new treatments in the shadow of the pharmaceutical industry. Today all that has changed; biotechnology has not only emerged from the shadows, it has grown up to become a significant part of the state’s innovation economy...

Everyone has a stake in the future of the state’s innovation industry, not just its employees and shareholders, but also all of the supporters and beneficiaries of the innovation pipeline — from universities and academic research centers to venture capital firms, from hospitals to manufacturers, from patients to their physicians. They must now work together to preserve the innovation industry’s independence, invest in its future and strengthen the collaborative ties that will preserve the state’s vital R&D capabilities.

Link to Full Article: http://www.boston.com/bostonglobe/editorial_opinion/oped/articles/2010/04/1…